Related references
Note: Only part of the references are listed.Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
Ritika Gera et al.
SCIENTIFIC REPORTS (2020)
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis
Elvire Pons-Tostivint et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Understanding Propensity Score Analyses
Nafisha Lalani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research
Abhishek Kumar et al.
JAMA NETWORK OPEN (2020)
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
Liselotte M. S. Boeve et al.
EUROPEAN UROLOGY (2019)
Comparison of Population-Based Observational Studies With Randomized Trials in Oncology
Payal D. Soni et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Selection Bias in Population Registry-Based Comparative Effectiveness Research
Payal D. Soni
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
Many Analysts, One Data Set: Making Transparent How Variations in Analytic Choices Affect Results
R. Silberzahn et al.
ADVANCES IN METHODS AND PRACTICES IN PSYCHOLOGICAL SCIENCE (2018)
Using the National Cancer Database for Outcomes Research
Daniel J. Boffa et al.
JAMA ONCOLOGY (2017)
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
Chad G. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
HISTORY OF CLINICAL TRIALS The Emergence of the Randomized, Controlled Trial
Laura E. Bothwell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations
Chirag J. Patel et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
Rajendra Badwe et al.
LANCET ONCOLOGY (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Immortal Time Bias: A Frequently Unrecognized Threat to Validity in the Evaluation of Postoperative Radiotherapy
Henry S. Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Bias Due to Left Truncation and Left Censoring in Longitudinal Studies of Developmental and Disease Processes
Kevin C. Cain et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The National Cancer Data Base: A powerful initiative to improve cancer care in the United States
Karl Y. Bilimoria et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Surgical treatment of primary lung cancer with synchronous brain metastases
PS Billing et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Share Paper
